Changes in renal function after discontinuation of vitamin D analogues in advanced chronic kidney disease

Nefrologia (Engl Ed). 2018 Mar-Apr;38(2):179-189. doi: 10.1016/j.nefro.2017.05.012. Epub 2017 Jul 1.
[Article in English, Spanish]

Abstract

Background: In routine clinical practice, the prescription of vitamin D analogues (VDA) in patients with chronic kidney disease (CKD) is often associated with a decline of the estimated renal function. The reason for this is not fully understood.

Aims: To analyse the effects of VDA discontinuation in advanced CKD and to determine the factors associated with changes in renal function.

Material and methods: Retrospective cohort study of adult patients with advanced CKD. The case subgroup was treated with VDA and this medication was discontinued at baseline (the first visit). The control subgroup was not treated with VDA and they were selected according to comparability principles for CKD progression by propensity score matching. The primary outcome measure was a change to both the estimated glomerular filtration rate (MDRD-GFR) and the measured glomerular filtration rate (mGFR by combined creatinine and urea clearances). Baseline parameters related to mineral metabolism and creatinine generation were analysed as potential determinants of renal function changes.

Results: The study sample consisted of 67 cases and 67 controls. Renal function improved in 67% of cases and worsened in 72% of controls (p<0.0001). Changes in MDRD-GFR for the case subgroup and the control subgroup were +0.455±0.997 vs. -0.436±1.103ml/min/1.73 m2/month (p<0.0001), respectively. Total creatinine excretion was slightly higher in cases than in controls but the difference was not significant. According to multivariate logistic and linear regression analyses, baseline total serum calcium was one of the best determinants of both renal function recovery (Odds ratio=3.49; p=0.001), and of the extent of renal function recovery (beta=0.276; p=0.001).

Conclusions: Discontinuation of VDA treatment in CKD patients is associated with significant recovery of estimated renal function. The extent of these changes is mainly associated with baseline total serum calcium.

Keywords: Análogos de la vitamina D; Chronic kidney disease progression; Creatinine generation; Generación de creatinina; Hipercalcemia; Hiperfosforemia; Hypercalcaemia; Hyperphosphataemia; Progresión de la enfermedad renal crónica; Vitamin D analogues.

MeSH terms

  • Aged
  • Calcium / blood
  • Case-Control Studies
  • Chronic Kidney Disease-Mineral and Bone Disorder / drug therapy
  • Chronic Kidney Disease-Mineral and Bone Disorder / etiology
  • Creatinine / blood
  • Female
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Kidney / physiopathology
  • Kidney Function Tests
  • Male
  • Middle Aged
  • Proteinuria / etiology
  • Recovery of Function
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / physiopathology*
  • Retrospective Studies
  • Vitamin D / administration & dosage
  • Vitamin D / adverse effects*
  • Vitamin D / analogs & derivatives
  • Vitamin D / therapeutic use

Substances

  • Vitamin D
  • Creatinine
  • Calcium